Are Onshore and Offshore 'Really' Different? — Common Sense Destroyed by Statistics

Onshore is safe, offshore is cheap' — has that belief been verified? Is the basis for your budget allocation truly numbers, ...

Reported as a 'success' in statistics, but no real-world impact—how to measure the 'true effect' hidden by p-values

Six months since the introduction of code reviews. Bug reports haven't decreased, and delivery speed remains unchanged. Yet, ...
newswire

Dermata’s XYNGARI(TM) Phase 3 Trial Hits Statistically Significant Difference at 4 Weeks

SAN DIEGO, CA, April 15, 2025 (Newswire.com) - Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of ...
The American Journal of Managed Care

Meta-Analysis Finds No Significant NSCLC Survival Differences With ICIs, but Trial Diversity Remains Limited

ICIs have transformed NSCLC treatment, but disparities in trial enrollment and efficacy reporting persist, limiting insights into treatment benefits across demographics. A meta-analysis of 21 trials ...
streetinsider

Dermata’s XYNGARI(TM) Phase 3 Trial Hits Statistically Significant Difference at 4 Weeks

In the intent to treat analysis, Dermata saw statistically significant differences in IGA treatment success, inflammatory lesion count, and non-inflammatory lesion count at week 4 (earliest measured ...